Connect
MJA
MJA

Extensively drug-resistant tuberculosis hovers threateningly at Australia’s door

Tony Kirby
Med J Aust 2013; 198 (7): 355. || doi: 10.5694/mja13.10178

Tony Kirby explains why we should provide full care to all people arriving with resistant tuberculosis

It was hoped that extensively drug-resistant tuberculosis (XDR-TB) might never arrive on Australia’s shores. But new cases raise the spectre of death for patients, transmission to others and large costs for Australian taxpayers. Papua New Guinea (PNG) national Catherina Abraham, aged 20 years, “made it” to Australia and hit the headlines in October 2012 because she had been diagnosed with XDR-TB.1 After almost a year in an isolation ward at Cairns Base Hospital, she died on 8 March 2013. Her treatment cost Queensland Health about $500 000 and would have cost $1 million had she lived to complete it.1 Now another PNG national has been diagnosed with XDR-TB in Australia. In the preceding 8 years, only two other XDR-TB cases were recorded in Australia.2

Please login with your free MJA account to view this article in full

  • Tony Kirby1,2

  • * The Lancet Journals (2007–2012), London, UK.

Correspondence: tony@tonykirby.com

Competing interests:

No relevant disclosures.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.